Terkko Navigator / Clinical Pharmacokinetics

Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)

Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions

Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease

Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development

Population Pharmacokinetics of Levetiracetam: A Systematic Review

Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance

Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults

Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis

Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib

Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration

Clinical Pharmacokinetics of Daptomycin

Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination

Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation

Modernization and Strengthening of Bioequivalence Guidelines in Japan

Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients

Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?

Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment

Acknowledgement to Referees

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression

The Influence of Haemostatic System Maturation on the Dose–Response Relationship of Unfractionated Heparin

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease

Comment on“Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Pharmacokinetics and Clinical Implications of Oral Semaglutide for Type 2 Diabetes Mellitus

Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action

Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria

Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib

Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers

Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients

Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation

Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations

Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain

Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019

A Quantitative Enterohepatic Circulation Model: Development and Evaluation with Tesofensine and Meloxicam

Use of Target Controlled Infusion to Derive Age and Gender Covariates for Propofol Clearance

Clinical Pharmacokinetics of Atypical Antipsychotics: A Critical Review of the Relationship Between Plasma Concentrations and Clinical Response

The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs: Pharmacokinetic and Therapeutic Implications

Predicting Pharmacokinetic Food Effects Using Biorelevant Solubility Media and Physiologically Based Modelling